|
2014-09-03 |
2014-09-02 |
PS
Planned sale
|
Powell Andrew Kenneth William
EVP, GC & Secretary
Officer
|
7,500
-19.5%
73.47
USD 551,035
|
7,500
-19.5%
|
73.47
|
USD 551,035
|
|
|
2014-08-20 |
2014-08-15 |
PS
Planned sale
|
Di Nepi Giacomo
EVP Managing Director, Europe
Officer
|
10,000
-25.9%
51.28
USD 512,752
|
10,000
-25.9%
|
51.28
|
USD 512,752
|
|
|
2014-08-14 |
2014-08-13 |
PS
Planned sale
|
ARATA PAUL D
EVP, Human Resources & Admin
Officer
|
7,500
-25.5%
50.00
USD 375,000
|
7,500
-25.5%
|
50.00
|
USD 375,000
|
|
|
2014-08-14 |
2014-08-13 |
PS
Planned sale
|
Nolan Sean P.
EVP & CBO
Officer
|
17,000
-20.6%
50.00
USD 850,000
|
17,000
-20.6%
|
50.00
|
USD 850,000
|
|
|
2014-08-07 |
2014-08-07 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
24,900
-20.9%
45.17
USD 1,124,813
|
24,900
-20.9%
|
45.17
|
USD 1,124,813
|
|
|
2014-08-07 |
2014-08-05 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
146,125
-60.8%
44.95
USD 6,568,684
|
146,125
-60.8%
|
44.95
|
USD 6,568,684
|
|
|
2014-07-17 |
2014-07-15 |
PS
Planned sale
|
Leff Jonathan A
EVP, Research & Development
Officer
|
35,000
-43.1%
43.08
USD 1,507,709
|
35,000
-43.1%
|
43.08
|
USD 1,507,709
|
|
|
2014-06-20 |
2014-06-18 |
PS
Planned sale
|
Nolan Sean P.
EVP & CBO
Officer
|
10,000
-13.2%
47.10
USD 471,000
|
10,000
-13.2%
|
47.10
|
USD 471,000
|
|
|
2014-06-18 |
2014-06-16 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
15,000
-13.7%
45.02
USD 675,252
|
15,000
-13.7%
|
45.02
|
USD 675,252
|
|
|
2014-06-13 |
2014-06-13 |
PS
Planned sale
|
Nolan Sean P.
EVP & CBO
Officer
|
10,000
-13.2%
44.35
USD 443,500
|
10,000
-13.2%
|
44.35
|
USD 443,500
|
|
|
2014-06-13 |
2014-06-06 |
PS
Planned sale
|
Nolan Sean P.
EVP & CBO
Officer
|
10,000
-13.2%
41.25
USD 412,500
|
10,000
-13.2%
|
41.25
|
USD 412,500
|
|
|
2014-08-20 |
2014-06-04 |
S
Sale
|
Di Nepi Giacomo
EVP Managing Director, Europe
Officer
|
12,085
-29.7%
39.79
USD 480,902
|
12,085
-29.7%
|
39.79
|
USD 480,902
|
|
|
2014-06-03 |
2014-05-30 |
S
Sale
|
Powell Andrew Kenneth William
EVP, GC & Secretary
Officer
|
500
-1.6%
39.32
USD 19,662
|
500
-1.6%
|
39.32
|
USD 19,662
|
|
|
2014-06-03 |
2014-05-29 |
S
Sale
|
Powell Andrew Kenneth William
EVP, GC & Secretary
Officer
|
500
-1.6%
39.56
USD 19,780
|
500
-1.6%
|
39.56
|
USD 19,780
|
|
|
2014-06-02 |
2014-05-29 |
S
Sale
|
KABAKOFF DAVID S
Non-Executive Director
|
5,000
-18.8%
39.56
USD 197,800
|
5,000
-18.8%
|
39.56
|
USD 197,800
|
|
|
2014-05-28 |
2014-05-27 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
6,949
-6.9%
40.15
USD 278,970
|
6,949
-6.9%
|
40.15
|
USD 278,970
|
|
|
2014-06-04 |
2014-05-23 |
PS
Planned sale
|
ARATA PAUL D
EVP, Human Resources & Admin
Officer
|
10,000
-30.5%
40.00
USD 400,000
|
10,000
-30.5%
|
40.00
|
USD 400,000
|
|
|
2014-05-28 |
2014-05-23 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
34,544
-26.9%
40.01
USD 1,381,974
|
34,544
-26.9%
|
40.01
|
USD 1,381,974
|
|
|
2014-05-21 |
2014-05-19 |
PS
Planned sale
|
WELCH DANIEL G
Charman, CEO and President
Executive Director
|
11,607
-11.0%
38.00
USD 441,066
|
11,607
-11.0%
|
38.00
|
USD 441,066
|
|
|
2014-05-07 |
2014-05-06 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
31,519
-24.3%
36.01
USD 1,135,012
|
31,519
-24.3%
|
36.01
|
USD 1,135,012
|
|
|
2014-05-07 |
2014-05-05 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
28,913
-22.8%
33.39
USD 965,370
|
28,913
-22.8%
|
33.39
|
USD 965,370
|
|
|
2014-03-05 |
2014-03-04 |
PS
Planned sale
|
Leff Jonathan A
EVP of R&D
Officer
|
20,000
-30.0%
31.51
USD 630,286
|
20,000
-30.0%
|
31.51
|
USD 630,286
|
|
|
2014-03-05 |
2014-03-04 |
S
Sale
|
Di Nepi Giacomo
EVP, Managing Director, Europe
Officer
|
70,000
-72.6%
30.84
USD 2,158,695
|
70,000
-72.6%
|
30.84
|
USD 2,158,695
|
|
|
2014-02-27 |
2014-02-25 |
PS
Planned sale
|
HODGMAN JOHN
EVP-Finance & CFO
Officer
|
73,130
-73.6%
35.69
USD 2,610,010
|
73,130
-73.6%
|
35.69
|
USD 2,610,010
|
|
|
2014-02-27 |
2014-02-25 |
PS
Planned sale
|
HODGMAN JOHN
EVP-Finance & CFO
Officer
|
86,355
-46.5%
35.69
USD 3,082,010
|
86,355
-46.5%
|
35.69
|
USD 3,082,010
|
|
|
2014-02-27 |
2014-02-25 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
41,087
-23.0%
32.63
USD 1,340,767
|
41,087
-23.0%
|
32.63
|
USD 1,340,767
|
|
|
2013-10-03 |
2013-10-01 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
70,000
-30.8%
15.43
USD 1,080,016
|
70,000
-30.8%
|
15.43
|
USD 1,080,016
|
|
|
2013-09-04 |
2013-08-30 |
S
Sale
|
KABAKOFF DAVID S
|
10,002
-24.7%
14.82
USD 148,245
|
10,002
-24.7%
|
14.82
|
USD 148,245
|
|
|
2013-08-28 |
2013-08-27 |
B
Purchase
|
Russell Angus C.
Non-Executive Director
|
4,950
+53.8%
14.37
USD 71,130
|
4,950
+53.8%
|
14.37
|
USD 71,130
|
|
|
2013-08-28 |
2013-08-26 |
B
Purchase
|
Russell Angus C.
Non-Executive Director
|
1,650
+21.8%
15.00
USD 24,743
|
1,650
+21.8%
|
15.00
|
USD 24,743
|
|
|
2011-07-27 |
2011-07-27 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
1,800
-2.8%
35.16
USD 63,286
|
1,800
-2.8%
|
35.16
|
USD 63,286
|
|
|
2011-07-21 |
2011-07-20 |
PS
Planned sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
7,290
-14.1%
36.25
USD 264,242
|
7,290
-14.1%
|
36.25
|
USD 264,242
|
|
|
2011-07-21 |
2011-07-20 |
PS
Planned sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
7,250
-14.0%
36.23
USD 262,694
|
7,250
-14.0%
|
36.23
|
USD 262,694
|
|
|
2011-07-14 |
2011-07-13 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
6,000
-8.9%
35.97
USD 215,848
|
6,000
-8.9%
|
35.97
|
USD 215,848
|
|
|
2011-07-07 |
2011-07-06 |
PS
Planned sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
7,250
-14.0%
35.84
USD 259,838
|
7,250
-14.0%
|
35.84
|
USD 259,838
|
|
|
2011-07-07 |
2011-07-06 |
PS
Planned sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
7,290
-14.1%
35.82
USD 261,118
|
7,290
-14.1%
|
35.82
|
USD 261,118
|
|
|
2011-06-30 |
2011-06-29 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
6,000
-8.9%
35.47
USD 212,836
|
6,000
-8.9%
|
35.47
|
USD 212,836
|
|
|
2011-06-23 |
2011-06-22 |
PS
Planned sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
7,290
-14.1%
32.03
USD 233,462
|
7,290
-14.1%
|
32.03
|
USD 233,462
|
|
|
2011-06-23 |
2011-06-22 |
PS
Planned sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
7,250
-14.0%
35.02
USD 253,909
|
7,250
-14.0%
|
35.02
|
USD 253,909
|
|
|
2011-06-23 |
2011-06-21 |
PS
Planned sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
7,290
-14.1%
35.00
USD 255,150
|
7,290
-14.1%
|
35.00
|
USD 255,150
|
|
|
2011-06-23 |
2011-06-21 |
PS
Planned sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
7,250
-14.0%
35.00
USD 253,750
|
7,250
-14.0%
|
35.00
|
USD 253,750
|
|
|
2011-06-23 |
2011-06-21 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
6,000
-8.9%
35.00
USD 210,000
|
6,000
-8.9%
|
35.00
|
USD 210,000
|
|
|
2011-06-22 |
2011-06-20 |
S
Sale
|
Seiwert Scott
SVP, Rsearch & Technical Dev.
Officer
|
6,297
-14.0%
33.22
USD 209,188
|
6,297
-14.0%
|
33.22
|
USD 209,188
|
|
|
2011-06-22 |
2011-06-20 |
S
Sale
|
Seiwert Scott
SVP, Rsearch & Technical Dev.
Officer
|
23,891
-34.6%
33.15
USD 791,987
|
23,891
-34.6%
|
33.15
|
USD 791,987
|
|
|
2011-06-22 |
2011-06-20 |
S
Sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
7,321
-14.1%
34.00
USD 248,914
|
7,321
-14.1%
|
34.00
|
USD 248,914
|
|
|
2011-06-22 |
2011-06-20 |
S
Sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
7,321
-14.1%
34.00
USD 248,914
|
7,321
-14.1%
|
34.00
|
USD 248,914
|
|
|
2011-06-21 |
2011-06-17 |
S
Sale
|
Steele Robin Joan
SVP, GC, Secretary
Officer
|
38,721
-71.4%
33.78
USD 1,307,995
|
38,721
-71.4%
|
33.78
|
USD 1,307,995
|
|
|
2011-06-15 |
2011-06-14 |
S
Sale
|
Cohen Alan Howard
SVP, Medical Affairs
Officer
|
20,849
-50.6%
33.00
USD 688,017
|
20,849
-50.6%
|
33.00
|
USD 688,017
|
|
|
2011-06-15 |
2011-06-14 |
S
Sale
|
Simon Howard Allan
SVP-Human Resources
Officer
|
21,213
-46.8%
33.00
USD 700,029
|
21,213
-46.8%
|
33.00
|
USD 700,029
|
|
|
2011-06-10 |
2011-06-08 |
S
Sale
|
Simon Howard Allan
SVP-Human Resources
Officer
|
9,578
-23.7%
33.00
USD 316,074
|
9,578
-23.7%
|
33.00
|
USD 316,074
|
|
|
2011-06-10 |
2011-06-08 |
S
Sale
|
Simon Howard Allan
SVP-Human Resources
Officer
|
21,176
-34.4%
32.64
USD 691,123
|
21,176
-34.4%
|
32.64
|
USD 691,123
|
|
|
2011-06-03 |
2011-06-02 |
S
Sale
|
KABAKOFF DAVID S
Non-Executive Director
|
2,000
-3.8%
36.41
USD 72,819
|
2,000
-3.8%
|
36.41
|
USD 72,819
|
|
|
2011-06-02 |
2011-06-01 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
6,000
-8.3%
36.79
USD 220,724
|
6,000
-8.3%
|
36.79
|
USD 220,724
|
|
|
2011-06-02 |
2011-06-01 |
S
Sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
3,226
-5.4%
37.01
USD 119,379
|
3,226
-5.4%
|
37.01
|
USD 119,379
|
|
|
2011-06-02 |
2011-06-01 |
S
Sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
3,186
-5.4%
36.50
USD 116,301
|
3,186
-5.4%
|
36.50
|
USD 116,301
|
|
|
2011-06-01 |
2011-05-31 |
S
Sale
|
Cohen Alan Howard
SVP, Medical Affairs
Officer
|
36,189
-57.3%
37.16
USD 1,344,762
|
36,189
-57.3%
|
37.16
|
USD 1,344,762
|
|
|
2011-05-20 |
2011-05-18 |
S
Sale
|
Simon Howard Allan
SVP-Human Resources
Officer
|
109,656
-73.1%
38.78
USD 4,252,602
|
109,656
-73.1%
|
38.78
|
USD 4,252,602
|
|
|
2011-05-19 |
2011-05-18 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
6,000
-8.3%
37.17
USD 223,018
|
6,000
-8.3%
|
37.17
|
USD 223,018
|
|
|
2011-05-19 |
2011-05-18 |
PS
Planned sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
1,811
-3.0%
37.05
USD 67,095
|
1,811
-3.0%
|
37.05
|
USD 67,095
|
|
|
2011-05-19 |
2011-05-18 |
PS
Planned sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
1,822
-3.0%
37.22
USD 67,822
|
1,822
-3.0%
|
37.22
|
USD 67,822
|
|
|
2011-05-18 |
2011-05-18 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
20,750
-7.4%
37.22
USD 772,323
|
20,750
-7.4%
|
37.22
|
USD 772,323
|
|
|
2011-05-18 |
2011-05-17 |
S
Sale
|
Di Nepi Giacomo
SVP, Managing Director, Europe
Officer
|
39,939
-61.9%
37.75
USD 1,507,817
|
39,939
-61.9%
|
37.75
|
USD 1,507,817
|
|
|
2011-05-18 |
2011-05-16 |
PS
Planned sale
|
WELCH DANIEL G
Chairman, CEO and President
Executive Director
|
3,505
-1.2%
38.22
USD 133,961
|
3,505
-1.2%
|
38.22
|
USD 133,961
|
|
|
2011-05-18 |
2011-05-16 |
S
Sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
958
-1.4%
37.78
USD 36,193
|
958
-1.4%
|
37.78
|
USD 36,193
|
|
|
2011-05-16 |
2011-05-13 |
S
Sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
1,918
-2.8%
39.85
USD 76,425
|
1,918
-2.8%
|
39.85
|
USD 76,425
|
|
|
2011-05-16 |
2011-05-12 |
PS
Planned sale
|
Steele Robin Joan
SVP, GC, Secretary
Officer
|
187,887
-75.3%
38.59
USD 7,250,315
|
187,887
-75.3%
|
38.59
|
USD 7,250,315
|
|
|
2011-05-16 |
2011-05-12 |
S
Sale
|
HODGMAN JOHN
SVP-Finance & CFO
Officer
|
143,227
-86.7%
40.00
USD 5,729,080
|
143,227
-86.7%
|
40.00
|
USD 5,729,080
|
|
|
2011-05-16 |
2011-05-12 |
S
Sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
131,332
-69.2%
40.14
USD 5,271,732
|
131,332
-69.2%
|
40.14
|
USD 5,271,732
|
|
|
2011-05-16 |
2011-05-12 |
S
Sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
115,842
-63.2%
38.84
USD 4,499,118
|
115,842
-63.2%
|
38.84
|
USD 4,499,118
|
|
|
2011-05-16 |
2011-05-12 |
S
Sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
88,311
-60.1%
38.89
USD 3,434,256
|
88,311
-60.1%
|
38.89
|
USD 3,434,256
|
|
|
2011-05-16 |
2011-05-12 |
S
Sale
|
Seiwert Scott
SVP, Rsearch & Technical Dev.
Officer
|
71,443
-60.3%
39.13
USD 2,795,229
|
71,443
-60.3%
|
39.13
|
USD 2,795,229
|
|
|
2011-05-05 |
2011-05-04 |
PS
Planned sale
|
Porter Steven Bryant
Chief Medical Officer
Officer
|
5,500
-8.7%
44.03
USD 242,164
|
5,500
-8.7%
|
44.03
|
USD 242,164
|
|
|
2011-05-05 |
2011-05-04 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
6,000
-8.3%
44.09
USD 264,565
|
6,000
-8.3%
|
44.09
|
USD 264,565
|
|
|
2011-05-05 |
2011-05-04 |
PS
Planned sale
|
ARMSTRONG MARIANNE
SVP Ch Reg & Drug Safety Off
Officer
|
5,651
-8.9%
44.03
USD 248,816
|
5,651
-8.9%
|
44.03
|
USD 248,816
|
|
|
2011-04-21 |
2011-04-20 |
PS
Planned sale
|
Bradford Williamson Z III
SVP-Clinical Science
Officer
|
6,000
-8.3%
46.43
USD 278,606
|
6,000
-8.3%
|
46.43
|
USD 278,606
|
|
